Three new radiopharmacy devices have been added to GE Medical Systems' line of Tracerlab chemistry synthesis products. The products, unveiled Oct. 24 at the Academy of Molecular Imaging conference, are used to generate positron-emitting
Three new radiopharmacy devices have been added to GE Medical Systems' line of Tracerlab chemistry synthesis products. The products, unveiled Oct. 24 at the Academy of Molecular Imaging conference, are used to generate positron-emitting radiopharmaceuticals. The Tracerlab FXFDopa, Tracerlab FXF-E, and Tracerlab FXF-N synthesize targeted F-18 radiopharmaceuticals for molecular imaging research. The devices are compatible with all commercially available cyclotrons, according to the company.
Mammography Study Compares False Positives Between AI and Radiologists in DBT Screening
May 8th 2025For DBT breast cancer screening, 47 percent of radiologist-only flagged false positives involved mass presentations whereas 40 percent of AI-only flagged false positive cases involved benign calcifications, according to research presented at the recent American Roentgen Ray Society (ARRS) conference.